Christopher Davis Davis Selected Advisers
Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$394M |
| 2 |
JPMorgan Chase
JPM
|
+$274M |
| 3 |
Quest Diagnostics
DGX
|
+$268M |
| 4 |
Moody's
MCO
|
+$198M |
| 5 |
UPL
Ultra Petroleum Corp. Common Stock
UPL
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$1.02B |
| 2 |
Progressive
PGR
|
+$670M |
| 3 |
Canadian Natural Resources
CNQ
|
+$548M |
| 4 |
Labcorp
LH
|
+$291M |
| 5 |
EOG Resources
EOG
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.39% |
| 2 | Healthcare | 12.23% |
| 3 | Communication Services | 11.2% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Technology | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$693B
| $402M | 1.19% |
7,628,040
-408,896
| -5% | -$21.4M |
|
27
Bausch Health
BHC
$2.41B
| $398M | 1.18% |
3,153,748
+435,586
| +16% | +$55.6M |
|
28
Sysco
SYY
$40.2B
| $393M | 1.17% |
10,503,009
+987,207
| +10% | +$36.3M |
|
29
Oracle
ORCL
$422B
| $348M | 1.04% |
8,590,789
-593,862
| -6% | -$24.4M |
|
|
ATVI
30
DELISTED
Activision Blizzard
ATVI
| $344M | 1.02% |
15,423,966
-1,407,614
| -8% | -$28.9M |
|
31
Chubb
CB
$132B
| $343M | 1.02% |
3,309,858
-175,732
| -5% | -$18M |
|
|
QVCGA
32
DELISTED
QVC Group Inc Series A
QVCGA
| $292M | 0.87% |
242,032
-19,347
| -7% | -$23.1M |
|
33
Brookfield
BN
$93.1B
| $277M | 0.82% |
26,924,095
-3,673,583
| -12% | -$36.7M |
|
|
34
Quest Diagnostics
DGX
$27B
| $274M | 0.82% |
4,672,681
+4,570,344
| +4,466% | +$268M |
|
|
MON
35
DELISTED
Monsanto Co
MON
| $249M | 0.74% |
1,995,210
-583,409
| -23% | -$68.3M |
|
36
Berkshire Hathaway Class B
BRK.B
$1.06T
| $248M | 0.74% |
1,961,337
-88,017
| -4% | -$11.1M |
|
|
PX
37
DELISTED
Praxair Inc
PX
| $248M | 0.74% |
1,868,017
-114,628
| -6% | -$15M |
|
38
Walt Disney
DIS
$186B
| $243M | 0.72% |
2,837,675
-455,008
| -14% | -$37.2M |
|
39
Markel Group
MKL
$22.2B
| $216M | 0.64% |
329,134
-18,111
| -5% | -$11.4M |
|
|
40
Moody's
MCO
$87.2B
| $211M | 0.63% |
+2,406,257
| New | +$198M |
|
|
QIHU
41
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $204M | 0.61% |
2,212,357
+643,036
| +41% | +$56.7M |
|
42
Textron
TXT
$14.3B
| $197M | 0.58% |
5,136,020
-373,981
| -7% | -$14.6M |
|
43
Philip Morris
PM
$293B
| $191M | 0.57% |
2,259,796
-339,847
| -13% | -$29.3M |
|
44
Netflix
NFLX
$331B
| $184M | 0.55% |
29,285,760
-2,574,320
| -8% | -$13.9M |
|
45
Harley-Davidson
HOG
$2.93B
| $182M | 0.54% |
2,610,372
-338,368
| -11% | -$23.8M |
|
46
Agilent Technologies
A
$44.9B
| $172M | 0.51% |
4,182,708
-356,436
| -8% | -$14.3M |
|
47
Everest Group
EG
$14.2B
| $162M | 0.48% |
1,010,277
-61,052
| -6% | -$9.66M |
|
|
SFUN
48
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $143M | 0.42% |
291,122
+86,018
| +42% | +$50.4M |
|
49
HP
HPQ
$27.2B
| $141M | 0.42% |
9,212,153
-826,452
| -8% | -$12.4M |
|
|
Y
50
DELISTED
Alleghany Corp
Y
| $141M | 0.42% |
321,251
-313,117
| -49% | -$131M |
|
Similar funds
Christopher Davis's Q2 2014 Portfolio in Review
As of Q2 2014, Christopher Davis held 188 positions worth $33.6B, down 7.4% from $36.3B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Christopher Davis withdrew a net $4.12B in Q2 2014, closing 8 positions and reducing 79 holdings. Its most notable exit was Bed Bath & Beyond Inc, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Christopher Davis opened a new position in Moody's worth $211M.
- Christopher Davis's largest Q2 2014 buy was Moody's: 2,406,257 shares worth $211M.
- Christopher Davis added most to Amazon in Q2 2014, an estimated $394M increase.
- Christopher Davis's biggest Q2 2014 reduction was Progressive, cutting an estimated $670M.
- Christopher Davis fully exited Bed Bath & Beyond Inc in Q2 2014, selling an estimated $1.02B.
- Christopher Davis's ten largest holdings make up 48% of its $33.6B portfolio in Q2 2014.
- Christopher Davis opened 13 new positions and closed 8 in Q2 2014.
- Christopher Davis's portfolio value fell 7.4% quarter-over-quarter to $33.6B.
Based on Davis Selected Advisers's 13F filing for Q2 2014, filed 13 Aug 2014.